Hysterectomy for heavy menstrual bleeding

Women's Health

Volumn 12, Issue 1, 2016, Pages 63-69

  Van Der Meij, Eva ^a   Emanuel, Mark Hans ^b  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b Department of Orthopaedic Surgery   (Netherlands)

Author keywords

abdominal hysterectomy; laparoscopic hysterectomy; oophorectomy; robot assisted hysterectomy; salpingectomy; subtotal or supravaginal hysterectomy; total hysterectomy; vaginal hysterectomy

Indexed keywords

ARTICLE; GYNECOLOGIC SURGERY; HUMAN; HYSTERECTOMY; MENORRHAGIA; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATION; SURGICAL APPROACH; TREATMENT INDICATION; FEMALE; PROCEDURES; UTERINE ARTERY EMBOLIZATION; UTERUS; VAGINAL HYSTERECTOMY; VASCULARIZATION; WOMEN'S HEALTH;

FEMALE; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; HYSTERECTOMY, VAGINAL; MENORRHAGIA; UTERINE ARTERY EMBOLIZATION; UTERUS; WOMEN'S HEALTH;

EID: 84955125438     PISSN: 17455057     EISSN: 17455065     Source Type: Journal    
DOI: 10.2217/whe.15.87     Document Type: Article

References (50)

1. Coulter A, Bradlow J, Agass M et al. Outcomes of referrals to gynaecology outpatient clinics for menstrual problems: an audit of general practice records. Br. J. Obstet. Gynaecol. 98, 789-796 (1991).
2. Coulter A, Kelland J, Peto V et al. Treating menorrhagia in primary care. An overview of drug trials and a survey of prescribing practice. Int. J. Technol. Assess. Health Care 11, 456-471 (1995).
3. Fergusson RJ, Lethaby A, Shepperd S, Farquhar C. Endometrial resection and ablation versus hysterectomy for heavy menstrual bleeding. Cochrane Database Syst. Rev. 11, CD000329 (2013).
4. Nieboer TE, Johnson N, Lethaby A et al. Surgical approach to hysterectomy for benign gynaecological disease. Cochrane Database Syst. Rev. 3, CD003677 (2009).
5. Sutton C. Hysterectomy: a historical perspective. Ball. Clin. Obstet. Gynaecol. 11, 1-22 (1997).
6. Varma R, Tahseen S, Lokugamage AU et al. Vaginal route as the norm when planning hysterectomy for benign conditions: change in practice. Obstet. Gynecol. 97, 613-616. (2001).
7. Tohic AL, Dhainaut C, Yazbeck C et al. Hysterectomy for benign uterine pathology among women without previous vaginal delivery. Obstet. Gynecol. 111, 829-837 (2008).
8. Agostini A, Bretelle F, Cravello L et al. Vaginal hysterectomy in nulliparous women without prolapse: a prospective comparative study. BJOG 110, 515-518 (2003).
9. Sizzi O, Paparella P, Bonito C et al. Laparoscopic assistance after vaginal hysterectomy and unsuccessful access to the ovaries or failed uterine mobilization: changing trends. JSLS 8, 339-346 (2004).
10. Agostini A, Vejux N, Colette E et al. Risk of bladder injury during vaginal hysterectomy in women with a previous cesarean section. J. Reprod. Med. 50(12), 940-942 (2005).
11. Sheth SS, Malpani AN. Vaginal hysterectomy following previous cesarean section. Int. J. Gynaecol. Obstet. 50, 165 (1995).
12. Unger JB, Meeks GR. Vaginal hysterectomy in women with history of previous cesarean delivery. Am. J. Obstet. Gynecol. 179, 1473-1478 (1998).
13. Ballard LA, Walters MD. Transvaginal mobilization and removal of ovaries and fallopian tubes after vaginal hysterectomy. Obstet. Gynecol. 87, 35-39 (1996).
14. Sheth SS. The place of oophorectomy at vaginal hysterectomy. Br. J. Obstet. Gynaecol. 98, 662-662 (1991).
15. Davies A, O'Connor H, Magos AL. A prospective study to evaluate oophorectomy at the time of vaginal hysterectomy. Br. J. Obstet. Gynaecol. 103, 915-920 (1996).
16. Harris WJ, Daniell JF. Early complications of laparoscopic hysterectomy. Obstet. Gynaecol. Surv. 51, 559-567 (1996).
17. Isik-Akbay EF, Harmanli OH, Panganamamula UR et al. Hysterectomy in obese women: a comparison of abdominal and vaginal routes. Obstet. Gynecol. 104, 710-714 (2004).
18. Rafii A, Samain E, Levardon M et al. Vaginal hysterectomy for benign disorders in obese women: a prospective study. BJOG 112, 223-227 (2005).
19. Rasmussen KL, Neumann G, Ljungström B et al. The influence of body mass index on the prevalence of complications after vaginal and abdominal hysterectomy. Acta Obstet. Gynecol. Scand. 83, 85-88 (2004).
20. Angioni S, Pontis A, Pisanu A et al. Single-port access subtotal laparoscopic hysterectomy: a prospective case-control study. J. Minim. Invasive Gynecol. 22(5), 807-812 (2015).
21. Lee J, Jennings K, Borahay MA et al. Trends in the national distribution of laparoscopic hysterectomies from 2003 to 2010. J. Minim. Invasive Gynecol. 21(4), 656-661 (2014).
22. Reich H, Roberts L. Laparoscopic hysterectomy in current gynaecological practice. Rev. Gynaecol. Pract. 3, 32-40 (2004).
23. Reich H, Decaprio J, McGlynn F. Laparoscopic hysterectomy. J. Gynecol. Surg. 5, 213-216 (1989).
24. Meeks GR. Advanced laparoscopic gynecologic surgery. Surg. Clin. North Am. 80, 1443-1464 (2000).
25. Gendy R, Walsh CA, Walsh SR et al. Vaginal hysterectomy versus total laparoscopic hysterectomy for benign disease: a metaanalysis of randomized controlled trials. Am. J. Obstet. Gynecol. 204, 388 (2011).
26. Candiani M, Izzo S, Bulfoni A et al. Laparoscopic vs vaginal hysterectomy for benign pathology. Am. J. Obstet. Gynecol. 200, 368.e1-7 (2009).
27. Pasic RP, Rizzo JA, Fang H et al. Comparing robot-assisted with conventional laparoscopic hysterectomy: impact on cost and clinical outcomes. J. Minim. Invasive Gynecol. 17, 730-738 (2010).
28. Uccella S, Ghezzi F, Mariani A et al. Vaginal cuff closure after minimally invasive hysterectomy: our experience and systematic review of the literature. Am.J. Obstet. Gynecol. 205, 119 (2011).
29. Choosing the route of hysterectomy for benign disease. ACOG Committee Opinion No. 444: choosing the route of hysterectomy for benign disease. Obstet. Gynecol. 114, 1156-1158 (2009).
30. Lethaby A, Mukhopadhyay A, Naik R. Total versus subtotal hysterectomy for benign gynaecological conditions. Cochrane Database Syst. Rev. 4, CD004993 (2012).
31. Storm HH, Clemmensen IH, Manders T et al. Supravaginal uterine amputation in Denmark 1978-1988 and risk of cancer. Gynecol. Oncol. 45(2), 198-201 (1992).
32. Thakar R, Ayers S. Outcomes after total versus subtotal abdominal hysterectomy. N. Engl. J. Med. 347(17), 1318-1325 (2002).
33. American College of Obstetricians and Gynecologists. Clinical Management Guidelines for Obstetrician-Gynecologists. ACOG Practice Bulletin 7. ACOG, Washington DC, USA, 643-648 (1999).
34. Orozco LJ, Salazar A, Clarke J et al. Hysterectomy versus hysterectomy plus oophorectomy for premenopausal women. Cochrane Database Syst. Rev. 3, CD005638 (2008).
35. Sightler SE, Boike GM, Estape RE et al. Ovarian cancer in women with prior hysterectomy: a 14 year experience at the University of Miami. Obstet. Gynecol. 78, 681-684 (1991).
36. Parker WH, Broder MS, Liu Z, Shoupe D, Farquhar C, Berek JS. Ovarian conservation at the time of hysterectomy for benign disease. Obst. Gynecol. 106(2), 219-226 (2005).
37. Christ JE, Lotze EC. The residual ovary syndrome. Obstet. Gynecol. 46, 551-556 (1975).
38. Holub Z, Jandourek M, Jabor A, Kliment L, Wagnerova M. Does hysterectomy without salpingo-oophorectomy influence the reoperation rate for adnexal pathology? Clin. Exper. Obstet. Gynecol. 27(2), 109-112 (2000).
39. Judd HL, Judd GE, Lucas WE et al. Endocrine function of the postmenopausal ovary: concentration of androgens and estrogens in ovarian and peripheral vein blood. J. Clin. Endocrin. Metabol. 39, 1020-1024 (1974).
40. Writing group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. Principal results from the Women's Health Initiative randomized controlled trial. JAMA 288, 321 (2002).
41. Vorwergk J, Radosa MP. Prophylactic bilateral salpingectomy (PBS) to reduce ovarian cancer risk incorporated in standard premenopausal hysterectomy: complications and re-operation rate. J. Cancer Res. Clin. Oncol. 140(5), 859-865 (2014).
42. Kurman RJ, Shih IeM. Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-shifting the paradigm. Hum. Pathol. 42(7), 918-931 (2011).
43. Sinha A. A randomized trial of endometrial ablation versus hysterectomy for the treatment of dysfunctional uterine bleeding: outcome at four years. Br. J. Obstet. Gynaecol. 106(4), 360-366 (1999).
44. Marjoribanks J1, Lethaby A, Farquhar C. Surgery versus medical therapy for heavy menstrual bleeding. Cochrane Database Syst. Rev. 2, CD003855 (2010).
45. Lethaby A, Hickey M, Garry R et al. Endometrial resection/ ablation techniques for heavy menstrual bleeding. Cochrane Database Syst. Rev. (4), CD001501 (2009).
46. Middleton LJ, Champaneria R, Daniels JP et al. Hysterectomy, endometrial destruction, and levonorgestrel releasing intrauterine system (Mirena) for heavy menstrual bleeding: systematic review and meta-analysis of data from individual patients. BMJ 341(7769), c3929 (2010).
47. Roberts TE, Tsourapas A, Middleton LJ et al. Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. BMJ 342, d2202 (2011).
48. Spilsbury K, Hammond I, Bulsara M et al. Morbidity outcomes of 78,577 hysterectomies for benign reasons over 23 years. BJOG 115, 1473 (2008).
49. Overton C, Hargreaves J, Maresh M. A national survey of the complications of endometrial destruction for menstrual disorders: the MISTLETOE study. Br. J. Obstet. Gynaecol. 104, 1351-1359 (1997).
50. Farquhar CM, Sadler L, Harvey SA et al. The association of hysterectomy and menopause: a prospective cohort study. BJOG 112(7), 956-962 (2005).